Franklin M. Berger, Director at Atea Pharmaceuticals, Inc. (AVIR), sold 719,212 shares at $2.85 ($2.0M) on 2024-12-10, disclosed to the SEC on 2024-12-12.
Open-market sale of $2.0M AVIR by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.85 | 359,606 | $1.0M | 50.0% |
| 2 | $2.85 | 359,606 | $1.0M | 50.0% |
| Total | $2.85 avg | 719,212 | $2.0M | 100% |
| Filing → |
| EPIX | BUY | 2023-11-16 | $518K | — | Filing → |
| EPIX | SELL | 2023-01-05 | $1.0M | — | Filing → |
| RAIN | BUY | 2022-11-23 | $988K | — | Filing → |